TGFB1 and preeclampsia: Using the SVM, we evaluated the performance of a single plasma cytokine as a predictor, and found, after cross-validation, that IL-22 (cross-validation accuracy = 75%) and TGF-β (cross-validation accuracy = 77%) displayed relatively high accuracy in discriminating between healthy controls and the patients with preeclampsia (Table S4).